Diagnos Inc.
TSX VENTURE : ADK

Diagnos Inc.

April 26, 2011 11:02 ET

DIAGNOS Announces Proposed Financing of up to $3,190,000

BROSSARD, QUEBEC--(Marketwire - April 26, 2011) - DIAGNOS inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE:ADK), a leader in the use of artificial intelligence and advanced knowledge extraction techniques, announces today a proposed non-brokered private placement of up to 11,000,000 units ("Units"), at a price of $0.29 per Unit, for gross proceeds of up to $3,190,000.

Each Unit is comprised of one Common Share and one-half of a Common Share purchase warrant (each full warrant, a "Warrant"). Each Warrant will entitle its holder to acquire one Common Share at a price of $0.40 at any time during the 18 months following the initial closing date (Period). Additionally, each Warrant will carry a forced conversion feature such that should the Common Shares of the Corporation trade at or above $0.60 for twenty consecutive trading days during the Period, then all of the Warrants shall be exercised within 30 days or they will automatically expire.

The securities to be issued in connection with this private placement are subject to a 4-month hold period and other requirements set by the TSX Venture Exchange.

Up to 6,000,000 Units are subject to finder's fees of 8% in cash on gross proceeds received by the Corporation. The finder is also entitled to 200,000 Warrants if gross proceeds from investors referred by the finder are $1,000,000 or more.

The Units will be sold in Canada on a prospectus-exempt basis. All monies quoted in this press release shall be stated and paid in lawful money of Canada.

This proposed private placement is subject to receipt of all required regulatory approvals, including that of the TSX Venture Exchange, as well as the negotiation and execution of formal documentation.

About DIAGNOS

Founded in 1998, DIAGNOS is a publicly traded Canadian corporation (TSX VENTURE:ADK), with a mission to commercialize technologies combining contextual imaging and traditional data mining thereby improving decision making processes. DIAGNOS offers products, services, and solutions to clients in a variety of fields including healthcare, natural resources, and entertainment.

For further information, please visit our website at www.diagnos.com or the SEDAR website at www.sedar.com.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this press release.

Contact Information